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Background: It remains unclear whether depression in-
creases the risk for dementia in the elderly. We evaluated
the relationship between depressed mood at baseline and
the incidence of dementia, particularly Alzheimer's dis-
ease, in the elderly living in the community.
Methods: A total of 1070 elderly individuals, aged 60
years or older, were identified as part of a registry for de-
mentia in the Washington Heights community of North
Manhattan, NY. In a prospective, longitudinal design with
follow-up for 1 to 5 years, annual physician evaluation
and neuropsychological testing were used to assess lev-
els of cognitive impairment and to diagnose dementia.
Depressive symptoms were evaluated with the 17-item
Hamilton Rating Scale for Depression. Based on clinical
considerations and a validity study, a positive score for
the depressed mood item was used in statistical analy-
ses. To confirm the results, the total Hamilton Rating Scale
for Depression score was also evaluated as the "depres-
sion" variable.
Results: Of the 1070 subjects, 218 met criteria for de-
mentia at baseline evaluation. In the 852 subjects with-
out dementia, depressed mood was more common in in-
dividuals with greater cognitive impairment. In a
follow-up study of 478 of these subjects without demen-
tia (mean\m=+-\SD,2.54\m=+-\1.12years of follow-up), the ef-
fect of baseline depressed mood on the end-point diag-
nosis of dementia (93% had possible or probable
Alzheimer's disease) was evaluated in a Cox propor-
tional hazards model. Depressed mood at baseline was
associated with an increased risk of incident dementia
(relative risk, 2.94; 95% confidence interval, 1.76 to 4.91;
P<.001). This effect remained after adjustment for age,
gender, education, language of assessment, Blessed
Memory Information and Concentration test scores, and
Blessed Functional Activity Scale scores (relative risk, 2.05;
95% confidence interval, 1.16 to 3.62; P<.02). Similar
results were obtained when the total Hamilton Rating Scale
for Depression score was used as the depression vari-
able, with the use of the same covariates (relative risk,
1.07 per point interval; 95% confidence interval, 1.02 to
1.11;P<.01).
Conclusions: Depressed mood moderately increased
the risk of developing dementia, primarily Alzheimer's
disease. Whether depressed mood is a very early mani-
festation of Alzheimer's disease, or increases suscepti-
bility through another mechanism, remains to be
determined.
(Arch Gen Psychiatry. 1996;53:175-182)
IN the elderly, it remains un¬clear whether depression in¬creases the risk of dementia. De¬pression may be associated withcognitive deficits, and some pa¬
tients with dementia manifest depressive
symptoms.1"6 Approximately 10% to 30%
of patients with Alzheimer's disease (AD)
meet criteria for major depression.7"10 How¬
ever, some symptoms used to diagnose
depressive disorders, including psycho-
motor change, apathy or lack of interest,
sleep difficulties, and disturbances in
thinking or concentration, frequently
occur in demented patients who are not
depressed.1113 These nonspecific symp¬
toms may artificially raise the reported
prevalence of depression in demented
patients.
In the clinically depressed elderly,
mild cognitive impairment is not uncom¬
mon.1415 This cognitive dysfunction im¬
proves to varying degrees once the depres¬
sive symptoms subside.1617 However, there
is growing evidence that some of these
clinically depressed patients with cogni¬
tive impairment develop irreversible de¬
mentia in 2 or more years,16·18·19 although
there are some dissenting reports.2021 In
clinical samples, follow-up studies indi¬
cate that cognitively intact elderly pa¬
tients with depression have only a slightly
higher probability of developing demen¬
tia than the general population.22·23
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SUBJECTS AND METHODS
SUBJECTS
All subjects provided written informed consent to partici¬
pate in the Washington Heights-Inwood and Columbia Ag¬
ing Project, a prospective investigation of AD and demen¬
tias associated with Parkinson's disease and stroke. Informed
consent was obtained from subjects and appropriate
advocates, as defined by the Columbia University (New
York, NY) institutional review board that approved this
project. Sources of potential subjects included referrals by
community-based health care providers, random samples
from a commercial list and a list obtained from the Health
Care Financing Agency, a state agency list of home care re¬
cipients, self-referred volunteers, and solicitation by news
media. Other details of subject recruitment to this com¬
munity registry have been described elsewhere.H3' Recruit¬
ment was limited to a geographically defined area of north¬
ern Manhattan.
The present study sample was selected by excluding
all subjects identified by a physician to have stroke (by his¬
tory or by focal neurologic signs or by radiologie evidence
consistent with stroke), Parkinson's disease, Huntington's
disease, multiple sclerosis, brain tumor, schizophrenia, or
mental retardation. Major depression was not an exclu¬
sion criterion. Subjects were examined at their residence(home or nursing home), senior citizen center, other com¬
munity facility, or in a research clinic. Follow-up was con¬
ducted with an identical set of evaluation procedures at
1-year intervals for a maximum of 5 years.
DIAGNOSTIC EVALUATION
All evaluations were conducted in either English or Span¬
ish, based on the subjects' primary language and their opin¬
ion of which language would yield better performance. A
physician obtained a semistructured medical history, con¬
ducted a physical and neurologic examination, completed
the modified short Blessed Memory Information and Con¬
centration test (BMIC),36 reviewed the Blessed Functional
Activity Scale (BFAS parts 1 and 2),34·36 and completed the
Clinical Dementia Rating.3' Prescribed medications were
reviewed and recorded. The physician, usually a neurolo-
gist or internist, also obtained a history of psycho tropic medi¬
cation use and electroconvulsive therapy and made the di¬
agnosis of major depression based on clinical impression.
The physician used DSM-ÍIÍ-R criteria38 as a guideline, but
there was no attempt to establish reliability of the physi¬
cian's diagnosis of major depression.
A research technician administered a standardized neu-
ropsychological test battery that assessed memory (verbal
and nonverbal), orientation, abstract reasoning, language,
and visuospatial abilities. These procedures have been de¬
scribed elsewhere.34
The initial diagnosis of dementia was based on a fixed
paradigm that used a priori cutoff scores on the neuropsy-
chological tests and evidence of impairment in social or oc¬
cupational function.34·35 These cutoff scores on neuropsy-
chological tests were established after the cognitive effects
of depression, stroke, and Parkinson's disease were taken into
account.34 As a result, the cutoff scores were conservative
enough to avoid misclassification of these three conditions
as dementia. The final diagnosis was based on a consensus
conference between physicians and neuropsychologists. The
diagnosis of dementia was based on the DSM-ÍÍÍ-R criteria
and required evidence of memory impairment and other cog¬
nitive deficits based on a neuropsychological test para¬
digm, as well as evidence of impairment in social or occu¬
pational function based on the formal functional assessment,
elicited history, or both. After this final consensus diagno¬
sis, subjects who were rated as demented were classified ac¬
cording to cause, based on the available medical and neu¬
rologic information. The criteria of the National Institute of
Neurological and Communicative Disorders and Stroke-
Alzheimer's Disease and Related Disorders Association39 were
used to make the diagnosis of possible or probable AD. In
this consensus diagnostic conference, there was no attempt
to classify depressive diagnoses according to DSM-ÍÍI-R.
Nondemented subjects were classified into one of three
categories: (1) no cognitive impairment (no more than one
neuropsychological test score below cutoffs, no func¬
tional impairment, and Clinical Dementia Rating of 0);(2) mild cognitive impairment (two or more test scores
below cutoffs, no functional impairment, and Clinical De¬
mentia Rating of 0); and (3) moderate cognitive impair¬
ment (two or more test scores below cutoffs, no func¬
tional impairment, and Clinical Dementia Rating of 0.5).
Follow-up evaluations were conducted at annual in-
Few epidemiologie studies have directly assessed de¬
pression as a risk factor for dementia, and many have ex¬
cluded depressed individuals during sample selection.24
These studies, mostly of the case-control type, suggest
that a history of medically treated depression is more com¬
mon in cases of dementia than in controls,25"31 with lim¬
ited contrary evidence.32 Overall, these studies suggest
that a history of depression slightly increases the risk of
dementia.24
Major limitations of many of these epidemiologie
studies include the use of a case-control design, reliance
on history of depression obtained primarily from medi¬
cal records and informant interviews, absence of direct
evaluation of depression, and low statistical power.33 To
our knowledge, there are no published longitudinal epi¬
demiologie studies that have used systematic assess¬
ments of depression and cognition to determine
whether depression is a risk factor for dementia. In a
prospective, longitudinal, population-based study that
used direct clinical evaluation of elderly subjects iden¬
tified from a community registry in a circumscribed
geographic area, we evaluated the relationship between




Baseline information was collected for 1070 subjects. Their
demographic and clinical features are described in
Table 1. The ethnic breakdown was 30% non-Latino
white, 41% Latino, and 27% African American, with 1%
in other categories. For some clinical variables, eg, psy-
Downloaded From: http://archpsyc.jamanetwork.com/pdfaccess.ashx?url=/data/journals/psych/12604/ by a Columbia University User  on 06/13/2017
tervals, with the use of the same diagnostic consensus con¬
ference procedures. Follow-up diagnoses were made with¬
out knowledge oí any baseline information. At the diag¬
nostic consensus conference, staff were aware of whether
the subject was depressed at that time. However, this did
not influence the diagnosis of dementia because the pri¬
mary dementia criterion, cognitive deficit, was based on a
fixed neuropsychological test score paradigm. In addi¬
tion, subjects were studied as part of a larger study with
goals unrelated to those of this report.
DEPRESSION
Two senior researchers formally trained and supervised the
interviewers in the use of the HRSD, with the aid of didac¬
tic sessions, videotapes, and in-person interviews. The
trained interviewer used a semistructured interview guide
to administer the 17-item HRSD to the patient.40 In de¬
mented subjects, additional information was obtained from
an informant.
To establish reliability, in a series of 52 elderly sub¬jects (32 patients with stroke and 20 normal controls; mean
age, 71.5 years), three trained raters and one clinical psy¬
chologist conducted interviews in pairs in which one rater
administered the scale and the other rater observed the in¬
terview. Both raters made independent ratings. Intraclass
correlation coefficients were .86 for the depressed mood
item and .96 for the total HRSD score.
In a separate validity study of 36 elderly subjects (13
patients with Parkinson's disease and 23 normal controls;
mean age, 73.4 years), a trained interviewer administered
the HRSD and a psychiatrist (S.T.) independently con¬
ducted the Structured Clinical Interview for DSM-ÍÍÍ-R38 to
diagnose major depressive disorder. In these 36 subjects, the
mean (±SD) HRSD score was 4.4±2.8. Six (17%) of these
36 subjects met criteria for major depressive disorder. For
the single HRSD item of depressed mood relative to the Struc¬
tured Clinical Interview for DSM-ÍÍÍ-R diagnosis of major de¬
pressive disorder, sensitivity was 83% and specificity was 70%.
Sensitivity and specificity were not improved further by the
inclusion of any other HRSD item, or by the total HRSD score(dichotomized as a 10 or < 10).
The symptoms of lack of interest, agitation, insom¬
nia, and weight loss are not uncommon in AD, and the
diagnosis ofmajor depression and the total HRSD score can
be misleading in such cases. Given these considerations,
and the results of the validity study, the HRSD depressed
mood item alone (dichotomized as present or absent) was
the main variable used for "depression" in statistical analy¬
ses. To confirm the results obtained with the depressed mood
item, the total HRSD score was also evaluated as the de¬
pression variable.
Recent evidence41·42 suggests a strong association be¬
tween the presence of the apolipoprotein E-e4 alíele and
AD. During the last year of the study, blood was drawn from
a subset of available subjects who consented to assess¬
ment of the apolipoprotein E genotype.
STATISTICAL ANALYSIS
Baseline Evaluation
Analyses by  2 or two-tailed Student's t tests were con¬
ducted to compare the demographic and clinical features
in subjects with and without dementia. Analyses of vari¬
ance and
 2 analyses were used to compare relevant de¬
mographic and clinical variables in the three subgroups with
no, mild, and moderate cognitive impairment. A logistic
regression model was used to assess the independent ef¬
fects of age, education, language, and depression on the di¬
agnosis of dementia.
Follow-up
Cox proportional hazards models43 were used to assess the
relative risk (RR) of incident dementia associated with de¬
pression. The timing variable was the duration from the
initial visit to the first follow-up time point at which the
diagnosis of dementia was made. Follow-up Cox analyses
were recalculated with adjustment for age, gender, educa¬
tion, language of assessment (English or Spanish), BMIC
scores (range, 0 to 28), and BFAS scores (range, 0 to 17).
In the sample subset in which apolipoprotein E geno¬
types were determined, subjects with the apolipoprotein
E-e4 alíele (homozygous or heterozygous) were classified
into one group, and the remaining subjects formed the other
group. The Cox proportional hazards model was used to
determine if the association of depression with incident de¬
mentia remained after accounting for the effect of apoli¬
poprotein E-e4 on disease risk.
chiatric history, information was not obtained, or could
not be obtained reliably, in 1% to 7% of subjects. Com¬
pared with the 852 subjects rated as not demented, the
218 demented patients were older, had less education,
and were more impaired on tests of cognition (BMIC)
and functional ability (BFAS). Of the demented sub¬jects, 89% were given a diagnosis of possible or prob¬
able AD with or without concomitant contributory
conditions.
Compared with subjects without dementia, the sub¬jects with dementia more frequently scored positively on
the HRSD depressed mood item and had significantly
higher HRSD total scores (Table 1). Patients with de¬
mentia were more likely to be prescribed anxiolytic medi¬
cations. The two groups did not differ with respect to a
history of psychiatric disorder or current or past treat¬
ment with antidepressant medications or electroconvul-
sive therapy (Table 1). The specific type of past psychi¬
atric disorder was not ascertained.
A logistic regression model was used to identify the
independent effects of median age (^74 years vs >74
years), education (<8 years vs >8 years), language (En¬
glish or Spanish), and depression on the diagnosis of de¬
mentia at baseline evaluation. Median age (RR, 6.22; 95%
confidence interval [CI], 4.17 to9.13;P<.001) and edu¬
cation (RR, 2.27; 95% CI, 1.53 to 3.36; P<.001) were
strongly associated, but depressed mood (RR, 1.34; 95%
CI, 0.96 to 1.87; P<.1) and language (RR, 1.38; 95% CI,
0.93 to 2.04; P=.ll) were not associated with the diag¬
nosis of dementia at baseline evaluation.
The degree of cognitive impairment was rated in 849
of the 852 subjects who were not demented at baseline
evaluation. Of the 849 subjects, 452 (53%) had no cog¬
nitive impairment, 243 (29%) had mild cognitive im-
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pairment, and 112 (13%) had moderate cognitive im¬
pairment. In these three subgroups, the demographic and
clinical features were compared (Table 2). There were
no differences in gender, history of psychiatric disor¬
der, or current psychotropic medication usage. Greater
cognitive impairment was associated with increased age,
lower education, and Spanish as the language of assess¬
ment. The presence of major depression as determined
by the physician's clinical impression, as well as posi¬
tive scores for the depressed mood item and the total
HRSD score, increased significantly with greater cogni¬
tive impairment.
In the 849 subjects without dementia, the sub¬
groups with and without a positive score for the HRSD
depressed mood item were compared on cognitive per¬
formance and functional ability. The depressed group per¬
formed more poorly on the BMIC (mean±SD, 4.9±4.4
vs 4.0±4.2; t=2.9, P<.005) and showed greater func¬
tional impairment on the BFAS (2.7±3.3 vs 1.5±2.6;
t=6.8, P<.001).
FOLLOW-UP SAMPLE
Of the 849 subjects rated not demented at baseline evalu¬
ation, at least one follow-up evaluation was conducted
in 478 subjects during a 1- to 5-year period (mean±SD
follow-up, 2.54± 1.12 years). The number of subj ects fol¬
lowed up at each time point was as follows: 391 at year
1, 346 at year 2, 216 at year 3, and 105 at year 4. Of the
353 subjects who were not followed up, 165 subjects were
recruited in the last year of the study, which has ended.
Reasons for failure to reexamine the others were death
(n=15), unavailability for follow-up or relocation (n=125),
and refusal (n=48). There were no significant differ¬
ences in gender, age, language, and depression scores be¬
tween subjects who were and were not followed up. Du¬
ration of follow-up was greater in subjects with a high
level of education compared with those with a low level
of education ( 2=9.2, P<.01). The mean (±SD) num¬
ber of years of education was 10.4±4.8 for subjects who
were followed up and 8.9±4.7 for subjects who were not
followed up.
The persistence of depressed mood over time was
evaluated in the subjects who were followed up. One hun¬
dred seven (62%) of the 173 subjects with depressed mood
at baseline had depressed mood at 1-year follow-up, and
75% of the 283 subjects without depressed mood at base¬
line did not have depressed mood at 1-year follow-up( 2=62.1, P<.001). Similarly, 63% of subjects with de¬
pressed mood at baseline had depressed mood at 2-year
follow-up, and 73% of subjects without depressed mood
at baseline did not have depressed mood at 2-year fol¬
low-up ( 2=42.8, P<.001). These findings suggested that
depressed mood was often an enduring symptom and pro¬
vided indirect evidence that the interviewers made con¬
sistent ratings during the study.
Of the 478 subjects who were followed up, 61
reached the end-point diagnosis of dementia. These 61
subjects comprised 36 (21%) of 173 subjects who were
depressed and 25 (9%) of 283 subjects who were not de¬
pressed at baseline evaluation ( 2=13.3, P<.001). At base¬
line evaluation, these 36 depressed subjects had higher
*BMIC indicates Blessed Memory Information and Concentration Test(range, 0 to 28); BFAS, Blessed Functional Activity Scale (parts 1 and 2;
range, 0 to 17); HRSD, Hamilton Rating Scale for Depression; and ECT,
electroconvulsive therapy.
 fA test of significance for  2 (categorical variables) or two-tailed t test(continuous variables), as appropriate.
depression (HRSD) and functional impairment (BFAS)
scores and were more likely to be Latino (Spanish-
speaking) than the 25 nondepressed subjects who de¬
veloped dementia on follow-up (Table 3). However, these
two groups did not differ in age, gender, duration from
the baseline visit to the final diagnosis of dementia, and
BMIC scores. The mean (±SD) HRSD score in the de¬
pressed group (9.0±6.1) indicated that the depressive
syndromes experienced by these subjects were often mild.
On the HRSD depressed mood item (scored 0 [absent]
to 4 [severely depressed]), 22 (61%) of these 36 de¬
pressed subjects received a score of 1,11 subjects (31%)
received a score of 2, three subjects (8%) received a score
of 3, and none received a score of 4. The 36 depressed
subjects who developed dementia on follow-up did not
differ significantly in baseline total HRSD scores(mean±SD, 9.0±6.1) from the 137 depressed subjects(7.5±4.9; t=1.56) who did not develop dementia on fol¬
low-up.
Fifty-seven (93%) of these 61 incident dementia cases
were classified as possible (n=9) or probable (n=48) AD.
Of the remaining four incident dementia cases, one had
progressive supranuclear palsy. The other three inci¬
dent dementia cases had a progressive clinical course con¬
sistent with AD but had other conditions (head injury,
alcohol dependence with motor vehicle accident, and mul¬
tiple sclerosis that developed after the initial evalua¬
tion) that were deemed contributing factors. Regardless
of dementia subtype, data for all subjects were retained
in the main analyses. A Cox proportional hazards model
evaluated the effect of baseline depressed mood on the
end-point diagnosis of dementia. The RR for reaching this
end point was significantly greater in subjects with de¬
pressed mood at baseline (RR, 2.94; 95% CI, 1.76 to 4.91;
P<.001). The Figure presents the survival curves for
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*BMIC indicates Blessed Memory Information and Concentration Test; BFAS, Blessed Functional Activity Scale (parts 1 and 2); ECT, electroconvulsive
therapy; and HRSD, Hamilton Rating Scale for Depression.
tLevel of significance in analysis of variance or  2, as appropriate.
^Diagnosis of major depression was based on the clinical impression of the physician, usually a neurologist or internist.
*HRSD indicates Hamilton Rating Scale for Depression; BMIC, Blessed
Memory Information and Concentration Test; and BFAS, Blessed Functional
Activity Scale (parts 1 and 2).
f/4 test of significance for
 2 (categorical variables) or two-tailed t test(continuous variables), as appropriate.
reaching dementia in subjects with and without depres¬
sion at baseline. The Cox proportional hazards model was
then recalculated with age, gender, education, lan¬
guage, and BMIC and BFAS scores included as covari-
ates. Baseline depressed mood remained significantly as¬
sociated with the end-point diagnosis of dementia (RR,
2.05; 95% CI, 1.16 to 3.62; P<.02). The covariates of age(RR, 1.11 per year interval; 95% CI, 1.07 to 1.15;P<.001),
education (RR, 1.97; 95% CI, 1.05 to 3.68; P<.05), BMIC
scores (RR, 1.14 per point interval; 95% CI, 1.08 to 1.20;
P<.001), and BFAS scores (RR, 1.14 per point interval;
95% CI, 1.02 to 1.28; P<.02) were significantly associ¬
ated with an increased risk of developing dementia on
follow-up; gender and language showed no significant
effects. Similar results were obtained when the four
non-AD cases were excluded, with depressed mood sig¬
nificantly associated with the diagnosis of AD on fol¬
low-up (RR, 1.91; 95% CI, 1.07 to 3.42; P=.03), and the
covariates of age, education, BMIC scores, and BFAS scores
showed significant effects.
With the use of the same covariates, the Cox analy¬
ses were repeated with the total HRSD score as the de¬
pression variable. The results were unchanged, with the
total HRSD score significantly associated with the end-
point diagnosis of dementia (RR, 1.07 per point inter¬
val; 95% CI, 1.02 to 1.11; P<.01), and the covariates of
age, education, BMIC scores, and BFAS scores showed
significant effects. Similar results were obtained with the
HRSD score dichotomized into high (^10) or low(<10) scores (RR, 2.16; 95% CI, 1.14 to 4.08; P<.02),
and the same covariates remained significantly associ¬
ated with an increased risk of developing dementia on
follow-up.
Of the 48 nondemented subjects with moderate cog¬
nitive impairment at baseline evaluation, 30 (62%) met
criteria for dementia on follow-up. One possibility is that
nearly all these subjects with moderate cognitive impair¬
ment would have met criteria for dementia if followed
up long enough. To control for the possibility that the
definition of moderate cognitive impairment in this study
was synonymous with very early dementia, the Cox pro¬
portional hazards model was recalculated after exclu¬
sion of these 48 subjects with moderate cognitive im¬
pairment. The results were unchanged, with the exception
that BFAS scores no longer showed a significant effect.
Baseline depression (RR, 2.31; 95% CI, 1.04 to 5.15;
P=.04), age (RR, 1.07 per year interval; 95% CI, 1.07 to
1.19; P<.001), education (RR, 3.85; 95% CI, 1.62 to 9.13;
P<.05), and BMIC scores (RR, 1.13 per point interval;
95% CI, 1.04 to 1.22; P<.01) were significantly associ¬
ated with an increased risk of developing dementia on
follow-up; gender, language, and BFAS scores showed no
significant effects.
In the subset of 121 subjects who were assessed for
the apolipoprotein E genotype, a Cox proportional haz¬
ards model evaluated the effect of age, baseline de¬
pressed mood, and the presence of the apolipoprotein E-e4











Time From Baseline to Dementia, mo
Cumulative survival for subjects with depressed mood at baseline
evaluation (dotted line) and for subjects without depressed mood at
baseline evaluation (solid line), as a function of time from baseline
evaluation to the diagnosis of dementia during follow-up.
alíele on the end-point diagnosis ofdementia. In this analy¬
sis, the magnitude of the RR for reaching this end point
was unchanged in subjects with depressed mood at base¬
line (RR, 2.82; 95% CI, 0.93 to 8.6; P=.07). The 33 sub¬
jects with the apolipoprotein E-e4 alíele manifested a sig¬
nificantly higher relative risk for incident dementia than
the 88 subjects without the apolipoprotein E-e4 alíele (RR,
4.79; 95% CI, 1.25 to 18.32; P=.02), and age showed a
significant effect (RR, 1.12peryearinterval;95%CI, 1.05
to 1.20;P<.001).
COMMENT
In community-residing elderly subjects without demen¬
tia, the presence of depressed mood was associated with
a moderately increased risk of dementia on follow-up.
This increased risk applied primarily to the develop¬
ment of AD, because at baseline evaluation (89%) and
during follow-up (93%) most subjects with dementia met
National Institute of Neurological and Communicative
Disorders and Stroke-Alzheimer's Disease and Related
Disorders Association criteria for possible or probable AD.
The presence of depressed mood conferred a RR of 2.05
after controlling for all the major clinical risk factors for
dementia that were evaluated, and remained significant
after the non-AD dementia cases were excluded. These
results were confirmed when similar results were ob¬
tained with the HRSD total score as the depression vari¬
able. In addition, in the subset in which the apolipopro¬
tein E genotype was assessed, factoring in the effect of
the apolipoprotein E-e4 alíele did not attenuate the
strength of the association between depressed mood and
incident dementia. Overall, the RR obtained in this pro¬
spective, longitudinal study is at the upper end of the range
of the RRs observed in other epidemiologie studies that
used case-control designs.24
In this study, the subjects were identified and re¬
cruited specifically for a community registry that exam¬
ined risk factors for dementia, and were not randomly
sampled from the general elderly population. As a re¬
sult, the proportion of subjects with dementia, and of sub¬jects with cognitive impairment but without dementia,
was high. At the baseline examination of subjects with-
out dementia, the prevalence of depressed mood was
higher in subjects with greater cognitive impairment, as
has been observed by others.31 This finding suggests that
depressed mood may be more a prodromal or early sign
than a risk factor for dementia.26·29·44 However, in the lon¬
gitudinal data set, when the Cox analyses were con¬
ducted after removal of the subgroup with moderate cog¬
nitive impairment at baseline evaluation, depressed mood
remained a risk factor for dementia. This argues against
the notion that depressed mood is more a prodromal or
early sign than a risk factor for dementia. Careful pro¬
spective assessment of the onset of depression and of cog¬
nitive decline would be necessary to address this issue
in future research.
Another possibility is that depression-induced cog¬
nitive dysfunction led subjects to meet criteria for de¬
mentia at an earlier time point without affecting the to¬
tal incidence. Several features of our study suggest that
this was unlikely. Depressive symptoms were predomi¬
nantly very mild to mild and therefore were unlikely to
result in cognitive impairment of a magnitude sufficient
to lead to the diagnosis of dementia. Of note, the cutoff
scores on the neuropsychological test paradigm for the
diagnosis of dementia were established after the cogni¬
tive effects of depression were taken into account and were
conservative enough to avoid misclassification. Inci¬
dent dementia was diagnosed only when there was mea¬
surable deterioration in cognitive performance and func¬
tional ability compared with baseline evaluation.
Therefore, it is unlikely that subjects had "depressive pseu-
dodementia" at baseline evaluation and later worsened
to meet criteria for dementia during follow-up.119
Other epidemiologie data, obtained primarily from
cross-sectional studies, have suggested a weak associa¬
tion between depression and cognitive impairment. In
North Carolina, 2% of a community sample had a de¬
pressive disorder and some cognitive impairment.4D In
the United Kingdom-United States cross-national diag¬
nostic project, Gurland et al44 reported no association be¬
tween depressive and cognitive symptoms in New York(r=.14) and in London (r=
—
.01). In an Australian com¬
munity study,46 eight of 274 met diagnostic criteria for
depression and dementia, a finding no different from that
expected by chance. However, there was a significant as¬
sociation between depressive and cognitive symptoms(r=.30). A recent study31 from Sweden found a complex
relationship between mood disturbance and cognitive im¬
pairment in 1304 community-residing subjects who were
aged 75 years or older. Depressive symptoms increased
as cognitive function declined, but a further cognitive
decline was associated with a decrease in depressive
symptoms.
Some of these discrepancies in the epidemiologie lit¬
erature may result from sample size and selection and
methods of ascertainment. In this study, the strengths
included the large sample size, the prospective design with
systematic follow-up, the direct evaluation of community-
residing subjects by physicians, detailed neuropsycho¬
logical assessment to evaluate cognitive impairment and
dementia, and the use of trained research personnel to
assess depressive symptoms with a standard rating in¬
strument. The use of these methods might have in-
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creased the sensitivity to detect the associations ob¬
served, in contrast to previous studies that used cross-
sectional designs and screening instruments to assess
cognitive status.
Most of the depressed subjects had mild symp¬
toms, a finding consistent with other epidemiologie data
in the elderly.24·47 In these mildly depressed subjects, there
was an increased RR for incident dementia. One limita¬
tion was that diagnostic subtype classification of the de¬
pressive illness, eg, major depression, dysthymic disor¬
der, or minor depression, was not attempted. It remains
unclear whether the 17-item HRSD is optimal to assess
depression in these subjects, and other instruments also
need to be evaluated in future research.48·49 Another limi¬
tation, inherent to all community studies of this type, is
that the most severely depressed subjects may have re¬
fused study participation. There was indirect evidence
that this did not occur, because at baseline evaluation there
was no difference in the severity of depression between
those subjects who subsequently did and did not par¬
ticipate in the follow-up phase. The follow-up rate was
less than ideal but was fairly good for a community study
with large minority representation.
Although exposure to minor tranquilizers and an-
tidepressants might be expected to be associated with cog¬
nitive impairment and an increased likelihood of a di¬
agnosis of dementia, the few case-control studies that have
examined this issue failed to find any association.26·27·32
In this study, the low frequency of antidepressant use
limited statistical power and precluded any definitive
conclusions.
The common occurrence of depression early dur¬
ing the course of intellectual deterioration has been pos¬
tulated to be secondary to awareness of eroding cogni¬
tive capacities.7 Depressed patients with AD have
degenerative changes in the noradrenergic nucleus lo¬
cus ceruleus and the substantia nigra,50 and this points
to catecholaminergic deficit as a possible mechanism for
the depression observed in some patients with AD. In ad¬
dition, there is evidence of degeneration of serotoniner-
gic neurons early in the course of AD.31 The onset of these
early degenerative changes may be associated with de¬
pression being a prodromal or early sign in a subgroup
of patients with AD. Other recent evidence indicates that
elderly patients with major depression, particularly those
with late onset, have elevated rates of baseline white mat¬
ter lesions and other structural abnormalities on mag¬
netic resonance images.52"55 However, whether this sub¬
group of depressed patients with subcortical lesions has
an increased risk of developing dementia remains to be
established. In our study, patients with historical or clini¬
cal or radiologie evidence of stroke were excluded. How¬
ever, computed tomographic scans and magnetic reso¬
nance images were not available in most of these
community-residing subjects, and the contribution of ce-
rebrovascular disease to the clinical picture could not be
ascertained.
In conclusion, using a prospective, longitudinal de¬
sign with detailed clinical assessment in a large sample
and controlling for a range of known risk factors, we found
depressed mood to be associated with a moderately in¬
creased risk of dementia, predominantly AD. Depres-
sion is known to worsen the prognosis in other illnesses
in the elderly, eg, stroke56 and myocardial infarction.57
However, it remains unclear whether successful treat¬
ment of depression delays the time point at which the
individual at risk meets clinical diagnostic criteria for AD.
Another unresolved question is whether depression is a
prodromal sign of AD or represents an intermediary fac¬
tor related in some way to another risk factor that has
yet to be identified. These issues need clarification in future
research.
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